Travera

📍 Medford, United States🗓 Founded 2017👥 13 employees💰 Last funded Apr 2021
Biotechnology Research🌐 travera.com
Website LinkedIn
Travera uses a breakthrough measurement tool invented at MIT to directly measure which cancer drugs are most likely to be effective for each individual cancer patient prior to them taking the drugs. The company offers CLIA certified Rapid Therapy Guidance Tests for all major cancers and 100+ FDA-approved cancer drugs, with a turnaround time of only two days.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Hong Kong SAR
1
United States
1
Frequently asked questions
Who invested in Travera?
Travera has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Travera last raise funding?
The most recent investment in Travera recorded on gritt.io was in April 2021.
When was Travera founded?
Travera was founded in 2017.
What industry is Travera in?
Travera operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Travera based?
Travera is headquartered in Medford, United States.